Tyme Technologies, Inc. (TYME) financial statements (2021 and earlier)

Company profile

Business Address 1 PLUCKEMIN WAY - SUITE 103
BEDMINSTER, NJ 07921
State of Incorp. DE
Fiscal Year End March 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
12/31/2015
11/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments13271429104 
Cash and cash equivalents13271429104 
Prepaid expense  00   
Other undisclosed current assets212200 
Total current assets:15281631114 
Noncurrent Assets
Operating lease, right-of-use asset00
Property, plant and equipment000000 
Other undisclosed noncurrent assets111    
Total noncurrent assets:111000 
TOTAL ASSETS:16301831114 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1221000
Accounts payable000000 
Accrued liabilities000000 
Employee-related liabilities1211   
Other undisclosed accounts payable and accrued liabilities      0
Debt 110   
Derivative instruments and hedges, liabilities    0  
Due to related parties      0
Other undisclosed current liabilities334331 
Total current liabilities:5665310
Noncurrent Liabilities
Long-term debt and lease obligation0      
Operating lease, liability0 
Other undisclosed noncurrent liabilities252    
Total noncurrent liabilities:252    
Total liabilities:71085310
Stockholders' equity
Stockholders' equity attributable to parent919102673(0)
Common stock0000000
Common stock, share subscribed but unissued, subscriptions receivable    (0)  
Common stock, value, subscriptions    0  
Additional paid in capital139127957941190
Accumulated deficit(130)(108)(86)(53)(34)(16)(0)
Total stockholders' equity:919102673(0)
TOTAL LIABILITIES AND EQUITY:16301831114 

Income statement (P&L) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
12/31/2015
11/30/2014
Operating expenses(25)(26)(32)(19)(15)(9)(0)
Operating loss:(25)(26)(32)(19)(15)(9)(0)
Nonoperating income3400 0 
Interest and debt expense(0)(0)   (4) 
Loss from continuing operations before equity method investments, income taxes:(22)(22)(32)(19)(15)(12)(0)
Other undisclosed income (loss) from continuing operations before income taxes00(1)    
Loss from continuing operations before income taxes:(22)(22)(33)(19)(15)(12)(0)
Income tax benefit      0
Loss before gain (loss) on sale of properties:(22)(22)(33)(19)(15)(12)(0)
Other undisclosed net income0      
Net loss:(22)(22)(33)(19)(15)(12)(0)
Other undisclosed net income (loss) attributable to parent0     (0)
Net loss available to common stockholders, diluted:(22)(22)(33)(19)(15)(12)(0)

Comprehensive Income ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
12/31/2015
11/30/2014
Net loss:(22)(22)(33)(19)(15)(12)(0)
Comprehensive loss, net of tax, attributable to parent:(22)(22)(33)(19)(15)(12)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: